+

WO1990005523A3 - Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase - Google Patents

Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase Download PDF

Info

Publication number
WO1990005523A3
WO1990005523A3 PCT/US1989/004774 US8904774W WO9005523A3 WO 1990005523 A3 WO1990005523 A3 WO 1990005523A3 US 8904774 W US8904774 W US 8904774W WO 9005523 A3 WO9005523 A3 WO 9005523A3
Authority
WO
WIPO (PCT)
Prior art keywords
phenanthrolinedicarboxylate
aminoquinoline
esters
inhibitors
reverse transcriptase
Prior art date
Application number
PCT/US1989/004774
Other languages
French (fr)
Other versions
WO1990005523A2 (en
Inventor
Irene W Althaus
Fritz Reusser
William Gary Tarpley
Louis L Skaletzky
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of WO1990005523A2 publication Critical patent/WO1990005523A2/en
Publication of WO1990005523A3 publication Critical patent/WO1990005523A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

This invention relates to a new medical use of some phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as drugs to treat human patients afflicted with a human immunodeficiency virus. The compounds have formulae (IA), (IB), (IC), (ID), where R, R1, R2, R', R'1, R'', R''1, R''2, R3, R4 and X are defined in Claim 1.
PCT/US1989/004774 1988-11-15 1989-10-30 Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase WO1990005523A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US27156788A 1988-11-15 1988-11-15
US271,567 1988-11-15
US27936488A 1988-12-02 1988-12-02
US279,364 1988-12-02
US28744888A 1988-12-20 1988-12-20
US287,448 1988-12-20

Publications (2)

Publication Number Publication Date
WO1990005523A2 WO1990005523A2 (en) 1990-05-31
WO1990005523A3 true WO1990005523A3 (en) 1990-07-12

Family

ID=27402391

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1989/004774 WO1990005523A2 (en) 1988-11-15 1989-10-30 Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase

Country Status (3)

Country Link
AU (1) AU4488989A (en)
CA (1) CA2002414A1 (en)
WO (1) WO1990005523A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3002700B2 (en) * 1990-08-29 2000-01-24 化研生薬株式会社 Anti-AIDS virus agent
EP0579695A1 (en) * 1991-03-14 1994-01-26 The Upjohn Company Reissert compounds as anti-hiv agents
JPH06504791A (en) * 1991-04-10 1994-06-02 オクタマー，インコーポレイティド Methods for inhibition of retrovirus replication
DE4344452A1 (en) * 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminoquinolines, process for their preparation and their use
DE69835430T2 (en) 1997-05-30 2007-03-08 Takeda Pharmaceutical Co. Ltd. Sulphonamide derivatives, their preparation and their use
US6403595B1 (en) 1998-02-05 2002-06-11 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, processes for producing the same and utilization thereof
KR20180086187A (en) 2015-10-05 2018-07-30 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 Clearance of protein aggregates including phospholipase D and tau, and treatment of protein diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790577A (en) * 1970-10-05 1974-02-05 Ici Ltd Pyridoquinoline dicarboxylic acid derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790577A (en) * 1970-10-05 1974-02-05 Ici Ltd Pyridoquinoline dicarboxylic acid derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts, vol. 104, no. 11, 17 March 1986,(Columbus, Ohio, US), Z. Szulc et al: "The syntheses and properties of tricyclic azines as potential interferon inducers and antivirus agents", see page 650, abstract 88460z, & Stud. Org. Chem. (Amsterdam) 1984, 18 (Bio-Org. Heterocycl.), 363-6 *

Also Published As

Publication number Publication date
CA2002414A1 (en) 1990-05-15
AU4488989A (en) 1990-06-12
WO1990005523A2 (en) 1990-05-31

Similar Documents

Publication Publication Date Title
DK602988A (en) NUCLEOSIDE DERIVATIVES WITH ANTIVIRAL EFFECT AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
MX9203543A (en) MEDICINE.
HK1011025A1 (en) 5,11-Dihydro-6h-dipyrido¬3,2-b:2'3'-e¾¬1,4¾diazepines and their use in the preventionor treatment of hiv infection
AU1189688A (en) Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states
CA2067381A1 (en) Treatment of hiv infections and compounds useful therein
AU1968992A (en) Preparation of fatty acid medicaments
IE873245L (en) Administering a deoxythymidine
EP0369887A3 (en) Use of trifluoromethyl phenyl-tetrahydropyridines in the manufacture of a medicament for the treatment of anxio-depressive disorders
DK284189A (en) PHARMACEUTICAL PRODUCTS
CA2179015A1 (en) Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
UA19756A1 (en) Process for preparation of piperazinyle-alkyl-3(2n)pyridazinones or pharmaceutically acceptable salts thereof
WO1990005523A3 (en) Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
DE69627160D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 3- (2,2,2-TRIMETHYLHYDRAZINIUM) PROPRIONATE AND GAMMA-BUTYROBETAIN FOR THE TREATMENT OF HEART Vascular DISEASES
EP0328924A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
RU94045248A (en) Method for inhibition of activation of virus of human immunodefficiency in vivo
DE3856052D1 (en) Use of the N-n-butyl derivative of deoxynojirimycin in the manufacture of a medicament for inhibiting the HIV virus
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
WO2000043014A8 (en) Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
WO1986006960A3 (en) Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
FI952018L (en) Use of BHAPs in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of HIV infection
NZ269990A (en) Inhibiting hiv viruses; use of azaspirane compounds in preparation of medicaments
FI871479A0 (en) Process for the preparation of perhydrothiazepine and perhydroazepine derivatives useful as medicaments
EP1731155A3 (en) Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 1989912025

Country of ref document: EP

AK Designated states

Kind code of ref document: A2

Designated state(s): AU DK FI HU JP KR NO SU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU DK FI HU JP KR NO SU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWW Wipo information: withdrawn in national office

Ref document number: 1989912025

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载